血液透析的透析液成分：变化与不断变化的风险
Dialysate Composition for Hemodialysis: Changes and Changing Risk.
作者信息
McGill Rita L, Weiner Daniel E
机构信息
Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
出版信息
Semin Dial. 2017 Mar;30(2):112-120. doi: 10.1111/sdi.12573. Epub 2017 Jan 8.
Abstract
Dialysate composition is a critical aspect of the hemodialysis prescription. Despite this, trial data are almost entirely lacking to help guide the optimal dialysate composition. Often, the concentrations of key components are chosen intuitively, and dialysate composition may be determined by default based on dialysate manufacturer specifications or hemodialysis facility practices. In this review, we examine the current epidemiological evidence guiding selection of dialysate bicarbonate, calcium, magnesium, and potassium, and identify unresolved issues for which pragmatic clinical trials are needed.
摘要
透析液成分是血液透析处方的一个关键方面。尽管如此，几乎完全缺乏试验数据来帮助指导最佳透析液成分的选择。通常，关键成分的浓度是凭直觉选择的，透析液成分可能默认根据透析液制造商的规格或血液透析机构的做法来确定。在本综述中，我们研究了目前指导透析液碳酸氢盐、钙、镁和钾选择的流行病学证据，并确定了需要进行务实临床试验的未解决问题。
相似文献
1
Dialysate Composition for Hemodialysis: Changes and Changing Risk.血液透析的透析液成分：变化与不断变化的风险
Semin Dial. 2017 Mar;30(2):112-120. doi: 10.1111/sdi.12573. Epub 2017 Jan 8.
2
Dialysis Prescription and Sudden Death.透析处方与猝死。
Semin Nephrol. 2018 Nov;38(6):570-581. doi: 10.1016/j.semnephrol.2018.08.003.
3
Dialysate Sodium: Rationale for Evolution over Time.透析液钠：随时间演变的原理
Semin Dial. 2017 Mar;30(2):99-111. doi: 10.1111/sdi.12570. Epub 2017 Jan 8.
4
Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.碳酸氢盐缓冲透析液对血液透析患者室性心律失常的影响。
Am J Nephrol. 2019;49(1):74-80. doi: 10.1159/000495846. Epub 2019 Jan 2.
5
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
6
7
Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis.高与低碳酸氢盐血液透析过程中的透析内酸碱变化和有机阴离子产生。
Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1418-F1429. doi: 10.1152/ajprenal.00036.2020. Epub 2020 Apr 20.
8
Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.血液透析患者的透析液钙实践与临床结局：一项回顾性观察研究。
Am J Kidney Dis. 2015 Oct;66(4):655-65. doi: 10.1053/j.ajkd.2015.03.038. Epub 2015 May 23.
9
[Treatment of electrolyte disorders by hemodialysis].[血液透析治疗电解质紊乱]
G Ital Nefrol. 2011 Jul-Aug;28(4):408-15.
10
Dialysate and serum potassium in hemodialysis.血液透析中的透析液和血清钾。
Am J Kidney Dis. 2015 Jul;66(1):125-32. doi: 10.1053/j.ajkd.2015.02.322. Epub 2015 Mar 28.
引用本文的文献
1
The Association of Serum Bicarbonate with Psychological and Physical Health-Related Quality of Life in Patients Receiving Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network (FHN) Daily Trial.维持性血液透析患者血清碳酸氢盐与心理和身体健康相关生活质量的关联：频繁血液透析网络（FHN）每日试验的二次分析
J Ren Nutr. 2025 Sep 3. doi: 10.1053/j.jrn.2025.05.007.
2
Functional Carbon-Based Materials for Blood Purification: Recent Advances Toward Improved Treatment of Renal Failure and Patient Quality of Life.用于血液净化的功能性碳基材料：改善肾衰竭治疗及患者生活质量的最新进展
Bioengineering (Basel). 2025 Aug 21;12(8):893. doi: 10.3390/bioengineering12080893.
3
Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care: A Comprehensive Review of Clinical Outcomes and Mechanisms.为何高容量后稀释血液滤过应成为透析治疗的新标准：临床结局与机制的全面综述
J Clin Med. 2025 Jul 9;14(14):4860. doi: 10.3390/jcm14144860.
4
Molecular frontiers in hemodialysis: unraveling the role of membranes in gene expression, epigenetics, and inflammatory pathways.血液透析的分子前沿：揭示膜在基因表达、表观遗传学和炎症途径中的作用
Int Urol Nephrol. 2025 Jun 25. doi: 10.1007/s11255-025-04613-z.
5
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease.一种用于从晚期慢性肾病患者中识别正在接受透析治疗患者的算法的开发与验证
Clin Exp Nephrol. 2025 May;29(5):650-661. doi: 10.1007/s10157-024-02614-3. Epub 2025 Jan 6.
6
Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study.透析研究监测中透析液碳酸氢盐与心律失常的关联
Kidney360. 2024 Oct 1;5(10):1490-1499. doi: 10.34067/KID.0000000000000537. Epub 2024 Aug 6.
7
Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance.稳定的初诊和复诊患者的血液透析程序可优化血流动力学稳定性、透析剂量、电解质及液体平衡。
J Clin Med. 2024 May 30;13(11):3211. doi: 10.3390/jcm13113211.
8
Bioengineered Kidney Tubules Efficiently Clear Uremic Toxins in Experimental Dialysis Conditions.生物工程化的肾小管在实验性透析条件下能有效清除尿毒症毒素。
Int J Mol Sci. 2023 Aug 4;24(15):12435. doi: 10.3390/ijms241512435.
9
Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy.连续性肾脏替代治疗期间电解质紊乱的管理
Electrolyte Blood Press. 2022 Dec;20(2):64-75. doi: 10.5049/EBP.2022.20.2.64. Epub 2022 Dec 30.
10
Tailoring the dialysate bicarbonate eliminates pre-dialysis acidosis and post-dialysis alkalosis.调整透析液碳酸氢盐可消除透析前酸中毒和透析后碱中毒。
Clin Kidney J. 2022 May 5;15(10):1946-1951. doi: 10.1093/ckj/sfac128. eCollection 2022 Oct.
本文引用的文献
1
Dialysate Sodium: Rationale for Evolution over Time.透析液钠：随时间演变的原理
Semin Dial. 2017 Mar;30(2):99-111. doi: 10.1111/sdi.12570. Epub 2017 Jan 8.
2
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).血液透析中透析液钾、血清钾、死亡率及心律失常事件：透析结局与实践模式研究（DOPPS）结果
Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17.
3
Serum magnesium is inversely associated with coronary artery calcification in the Genetics of Atherosclerotic Disease (GEA) study.在动脉粥样硬化疾病遗传学（GEA）研究中，血清镁与冠状动脉钙化呈负相关。
Nutr J. 2016 Mar 1;15:22. doi: 10.1186/s12937-016-0143-3.
4
Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.血液透析患者中质子泵抑制剂的使用与镁浓度：一项横断面研究。
PLoS One. 2015 Nov 30;10(11):e0143656. doi: 10.1371/journal.pone.0143656. eCollection 2015.
5
Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.慢性肾脏病中钙、磷和镁代谢紊乱的病理生理学
Semin Dial. 2015 Nov-Dec;28(6):564-77. doi: 10.1111/sdi.12411. Epub 2015 Aug 25.
6
Acid-Base Status and Mortality Risk in Hemodialysis Patients.血液透析患者的酸碱状态与死亡风险
Am J Kidney Dis. 2015 Sep;66(3):383-5. doi: 10.1053/j.ajkd.2015.06.008.
7
Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.血清镁与美国血液透析患者死亡率：一项队列研究。
Am J Kidney Dis. 2015 Dec;66(6):1056-66. doi: 10.1053/j.ajkd.2015.06.014. Epub 2015 Jul 17.
8
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.聚磺苯乙烯钠散对高钾血症合并糖尿病肾病患者血钾水平的影响：AMEHTYST-DN 随机临床试验。
JAMA. 2015 Jul 14;314(2):151-61. doi: 10.1001/jama.2015.7446.
9
Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.质子泵抑制剂与普通人群低镁血症：基于人群的队列研究。
Am J Kidney Dis. 2015 Nov;66(5):775-82. doi: 10.1053/j.ajkd.2015.05.012. Epub 2015 Jun 26.
10
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2014年年报：美国肾脏疾病流行病学
Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001.
Zotero 插件